Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)-Reference-Cited by-同舟云学术

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

Published:2015-07-07 Issue:1 Volume:15 Page:
ISSN:1471-2415
Container-title:BMC Ophthalmology
language:en
Short-container-title:BMC Ophthalmol

Author:

Schauwvlieghe A.M.E.,Dijkman G.,Hooymans J.M.,Verbraak F.D.,Hoyng C.B.,Dijkgraaf M.G.W.,Van Leeuwen R.,Vingerling J.R.,Moll A.C.,Schlingemann Reinier O.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

http://link.springer.com/article/10.1186/s12886-015-0043-x/fulltext.html

Reference20 articles.

1. Gelisken F, Ziemssen F. Diabetic maculopathy. Diagnosis and treatment. Ophthalmologe. 2010;107:773–86.

2. Chew EY, Ferris III FL, Csaky KG, Murphy RP, Agron E, Thompson DJ, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology. 2003;110:1683–9.

3. Diabetic retinopathy clinical resarch network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447–9, 1449.

4. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003;22:1–29.

5. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33:2399–405.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy;Journal of Clinical Medicine;2020-11-23

2. Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME);Ophthalmology Retina;2020-08

3. Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases;BMC Public Health;2019-09-11

4. Impacto orçamentário da incorporação de medicamentos para tratamento em segunda linha do edema macular diabético no SUS sob a perspectiva da Secretaria de Estado de Saúde de Minas Gerais, Brasil;Cadernos de Saúde Pública;2019

5. PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY;Retina;2018-04